Blood serum concentration of long-acting fluphenazine in patients with various forms of schizophrenia
Pempkowiak, L.; Januszkiewicz-Grabiasowa, A.; Góra, S.
Psychiatria Polska 13(1): 1-8
1979
ISSN/ISBN: 0033-2674 PMID: 419224 Document Number: 149239
Document emailed within 1 workday
Related Documents
Niturad, A.; Ciurezu, T.; Cucu, I. 1974: Maintenance treatment of schizophrenia with long-acting fluphenazine Activitas Nervosa Superior 16(3): 167Wintrob, R.M. 1970: Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment Diseases of the Nervous System 31(Suppl): 50-62
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Arunpongpaisal, S.; Srisurapanont, M.; Kongsakon, R.; Kitiwattanagul, K.; Samanwongthai, U. 2010: Risperidone long-acting injection (RLAI): the 12-week efficacy and tolerability in Thai patients with chronic schizophrenia Journal of the Medical Association of Thailand 93(3): 343-350
Fota-Markowska, H.; Modrzewska, R.; Bielec, D.; Lis, J.; Przbyła, A. 2002: Concentration of sVAP in serum of patients with different forms of Lyme borreliosis Przeglad Epidemiologiczny 56(Suppl 1): 79-85
Llorca, P-M.; Sacchetti, E.; Lloyd, K.; Kissling, W.; Medori, R. 2008: Long-term remission in schizophrenia and related psychoses with long-acting risperidone: results obtained in an open-label study with an observation period of 18 months International Journal of Clinical Pharmacology and Therapeutics 46(1): 14-22
Markocka-Maczka, K. 2003: Concentration of serum soluble forms of ICAM-1 (sVCAM-1) and VCAM-1 (sVCAM-1) in patients with chronic pancreatitis and in patients with pancreatic carcinoma Wiadomosci Lekarskie 56(3-4): 147-151
Johnson, D.A. 1984: Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia Journal of Clinical Psychiatry 45(5 Part 2): 13-21
Wu, L.; Janagam, D.R.; Mandrell, T.D.; Johnson, J.R.; Lowe, T.L. 2015: Long-acting injectable hormonal dosage forms for contraception Pharmaceutical Research 32(7): 2180-2191
Villani, F.; Bohnet, A.; Sakellaridès, E.; Schelling, J.L. 1975: Urinary concentration and antibacterial effect of short and long acting tetracycyline Schweizerische Medizinische Wochenschrift 105(11): 341-344
Mishchenko, B.P.; Bonartsev, P.D. 1974: Study of the damaging membranotropic action of the blood serum of schizophrenia patients in in vitro experiments Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 74(3): 391-396
Lucke, J.C.; Hall, W.D. 2012: Under what conditions is it ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception? Addiction 107(6): 1036-1041
Inagaki, A. 2016: Safety of Long-acting Injectable Antipsychotics Is Long-acting Injection a High-risk Treatment Option? Seishin Shinkeigaku Zasshi 118(8): 589-597
Landowski, J. 1977: Blood platelet MAO activity in various forms of schizophrenia Psychiatria Polska 11(5): 505-510
Kenway, A.K.; Masheter, H.C. 1971: Pimozide compared with fluphenazine in schizophrenia British Journal of Clinical Practice 25(2): 69-72
Lucke, J.C.; Hall, W.D. 2012: Exploring conditions under which it may be ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception Addiction 107(6): 1049-1050
Nazar, J.; Szymańska, A. 2000: Blood serum TNF-alpha concentration in patients with ischaemic and haemorrhagic brain stroke Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 55: 383-387
Trznadel, K.; Walasek, L.; Lutz, W.; Nagański, T.; Fajndt, S. 1977: Blood serum concentration and urinary excretion of myoinositol in patients with malignant tumors Polski Tygodnik Lekarski 32(46): 1785-1787
Thulin, T.; Lehtonen, A.; Dahlöf, C.; Nilsson-Ehle, P.; Engqvist, L.; Lagerstedt, C.; Berglund, E. 1999: Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group International Journal of Clinical Pharmacology and Therapeutics 37(1): 28-33
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270